Use of intra-aortic balloon counterpulsation in cardiogenic shock complicating acute myocardial infarction. Do we really need more evidence?

Critical Care Medicine

Volumn 38, Issue 1, 2010, Pages 321-322

  Ohlmann, Patrick ^a   Morel, Olivier ^a   Kindo, Michel ^a   Radulescu, Bogdan ^a   Kremer, Hélène ^a   Bareiss, Pierre ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

APACHE II scores; B type natriuretic peptide; Cardiogenic shock; Percutaneous coronary angioplasty

Indexed keywords

ARGININE; BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6;

ACUTE HEART INFARCTION; AORTA BALLOON; APACHE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUNTERPULSATION; EDITORIAL; FIBRINOLYTIC THERAPY; HEART INDEX; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CRITICAL ILLNESS; FEMALE; HEART INFARCTION; INTENSIVE CARE; INTENSIVE CARE UNIT; MALE; METHODOLOGY; NOTE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

APACHE; COUNTERPULSATION; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTRA-AORTIC BALLOON PUMPING; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; SHOCK, CARDIOGENIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 74049097067     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c30c67     Document Type: Editorial

References (13)

1. Babaev A, Frederick PD, Pasta DJ, et al: Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294:448-454
2. Hochman JS, Sleeper LA, Webb JG, et al: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardio-genic shock. N Engl J Med 1999; 341: 625-634
3. Webb JG, Lowe AM, Sanborn TA, et al: Percutaneous coronary intervention for cardio-genic shock in the SHOCK trial. J Am Coll Cardiol 2003; 42:1380-1386
4. Antman EM, Anbe DT, Armstrong PW, et al: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Manage-ment of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: E1-E211
5. Van de Werf F, Bax J, Betriu A, et al: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945
6. Barron HV, Every NR, Parsons LS, et al: The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141:933-939
7. Sjauw KD, Engström AE, Vis MM, et al: A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J 2009; 30:459-468
8. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003; 107: 2998-3002
9. Dzavík V, Cotter G, Reynolds HR, et al: Effect of nitric oxide synthase inhibition on haemo-dynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: A phase II dose-ranging study. Eur Heart J 2007; 28: 1109-1116
10. TRIUMPH Investigators, Alexander JH, Reynolds HR, et al: Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA 2007; 297: 1657-1666
11. Prondzinski R, Lemm H, Swyter M, et al: Intra-aortic ballon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38:152-160
12. Pilz G, Werdan K: Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock. Infection 1990; 18:253-262
13. Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et al: The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. J Am Coll Cardiol 2001; 38:1456-1462